What is the current market size?

The artificial intelligence in the medical imaging market size was valued at USD 1.2 billion in 2023, driven by adoption of AI for diagnostic accuracy and workflow efficiency.

What is the expected growth rate?

The future outlook predicts a CAGR of 4.8% from 2024 to 2030, fueled by AI integration in healthcare and rising demand for early disease detection.

What are the key growth drivers?

Key drivers include advancements in deep learning algorithms, increasing prevalence of chronic diseases, and the need for faster, accurate medical imaging analysis.

What challenges does the market face?

Challenges include data privacy concerns, high implementation costs, and lack of standardized AI models for medical imaging applications.

Which regions are leading the market?

North America leads due to robust healthcare IT infrastructure, followed by Europe and Asia-Pacific, where government initiatives are accelerating AI adoption.

Who are the top companies?

Leading companies include GE Healthcare, Siemens Healthineers, and Philips, leveraging AI for enhanced imaging solutions and diagnostic support.

What future opportunities exist?

Opportunities lie in AI-powered predictive analytics, AI-driven drug development, and expansion into emerging markets with underserved healthcare needs.

How is technology impacting the sector?

AI technologies like computer vision and machine learning are transforming medical imaging by enabling faster processing, anomaly detection, and personalized treatment planning.

What is the regulatory landscape?

Regulatory frameworks such as FDA’s AI/ML-based SaMD action plan and EU’s AI Act emphasize transparency, validation, and compliance for AI medical imaging tools.

artificial intelligence in the medical imaging Market Metrics & Forecast Analysis 2033

artificial intelligence in the medical imaging by Application (Hospitals, Diagnostic Centers), by Types (Digital Pathology, Oncology, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 25.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 25.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

artificial intelligence in the medical imaging Market Size | CAGR 25.4 Forecast 2033

artificial intelligence in the medical imaging Market Metrics & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 25.4%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 25.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

artificial intelligence in the medical imaging Market Overview

The artificial intelligence (AI) in the medical imaging market encompasses technologies that enhance diagnostic accuracy, streamline workflows, and improve patient outcomes through AI-driven analysis of imaging data. As a critical component of digital healthcare, AI in medical imaging is reshaping radiology, pathology, and surgical planning. The artificial intelligence in the medical imaging market size reached $1.3 billion in 2026, reflecting robust growth outlook fueled by advancements in deep learning algorithms and rising demand for precision diagnostics. This market forecast projects a CAGR of 28.6% from 2026 to 2033, driven by macro forces such as AI integration in multimodal imaging systems, regulatory tailwinds, and healthcare digitization. Key industry expansion catalysts include the proliferation of 3D imaging datasets, AI-enabled early disease detection, and partnerships between tech firms and healthcare providers.

Loading chart…

North America dominates the AI medical imaging market, leveraging advanced healthcare IT infrastructure and a high adoption rate of AI tools. Conversely, the Asia-Pacific region is emerging as the fastest-growing market, driven by rising healthcare investments, government initiatives for AI-enabled diagnostics, and an expanding middle-class population. Strategic mergers, such as Siemens Healthineers' AI partnerships and NVIDIA's Clara platform expansions, underscore competitive intensity. Regulatory frameworks like the FDA's real-world evidence programs further accelerate innovation, ensuring the artificial intelligence in the medical imaging market remains a pivotal frontier in healthcare evolution.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	7.34 billion
Growth rate	CAGR of 25.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	NVIDIA Corporation; GE Healthcare; Siemens; Aidoc; 3Scan; Agfa Healthcare; Arterys; Butterfly Network, Inc.; EchoNous, Inc.; Enlitic, Inc.; IBM Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Artificial intelligence in the medical imaging market is expanding due to rising demand for precision diagnostics, driven by advancements in deep learning algorithms that enhance anomaly detection in radiology, pathology, and cardiology. These technologies improve diagnostic accuracy while reducing interpretation time, aligning with healthcare providers' need for operational efficiency.

The global shift toward digitized healthcare infrastructure, supported by government initiatives to modernize medical facilities, is accelerating adoption. For instance, the U.S. FDA’s expanded clearance pathways for AI-based imaging tools are expediting commercialization, directly influencing artificial intelligence in the medical imaging market size growth.

Restraints2 items

Regulatory complexities, including stringent validation requirements for AI software as a medical device (SaMD), delay product launches and increase compliance costs. This is particularly evident in markets like the EU, where conformity assessments under the MDR (Medical Device Regulation) create bottlenecks.

Data privacy concerns and cybersecurity vulnerabilities in AI systems hinder trust. Hospitals and imaging centers face risks of data breaches, which could deter investment in AI solutions despite their clinical benefits.

Opportunities2 items

The integration of AI with growth forecast-driven telehealth platforms presents untapped potential, enabling remote diagnostics in underserved regions. Partnerships between AI developers and radiology networks could unlock revenue streams in emerging markets.

Advancements in multimodal AI models—combining imaging data with genomics and electronic health records (EHRs)—offer opportunities to pioneer predictive analytics for early disease detection, differentiating offerings in a competitive market.

Challenges2 items

High development costs for AI training datasets, coupled with the need for continuous algorithmic updates to address evolving disease patterns, strain R&D budgets. Small-to-midsize firms struggle to compete with large tech players in this capital-intensive space.

Interoperability issues between AI platforms and legacy hospital systems create friction in adoption. Legacy EHR systems often lack standardized APIs, requiring costly custom integrations that delay implementation timelines.

Market Segmentation

Loading chart…

Application is a critical axis of artificial intelligence in the medical imaging segmentation, reflecting functional use cases. Diagnostic imaging constitutes the largest segment, driven by AI's role in enhancing accuracy for conditions like cancer and cardiovascular diseases. Procedural guidance, which includes real-time AI assistance during surgeries, accounts for 28% of the market, reflecting its integration into minimally invasive techniques. Research and development applications, though smaller at 15%, are growing rapidly due to AI's ability to analyze large datasets for drug discovery and personalized medicine. These segments collectively define the market taxonomy, with diagnostic imaging dominating due to its maturity and high adoption rates in hospitals and radiology departments.

Types of AI in medical imaging are defined by algorithmic approaches and technical capabilities. Machine learning (ML) constitutes 45% of the market, focusing on pattern recognition for tasks like anomaly detection in X-rays and MRIs. Deep learning (DL), with a 35% share, leverages neural networks for complex tasks such as 3D image reconstruction and tumor classification. Hybrid models, which integrate ML and DL techniques, represent 15% of the market and are gaining traction for multi-modal imaging tasks. Reinforcement learning, at 5%, remains niche but is explored for adaptive radiology workflows. This segmentation underscores technological diversity, with deep learning driving innovation while machine learning maintains a dominant position in established applications.

artificial intelligence in the medical imaging Segmentation Breakdown7 items

Application

Hospitals

Diagnostic Centers

Types

Digital Pathology

Oncology

Others

Regional Insights

Loading chart…

North America dominates the artificial intelligence in the medical imaging market with a 35% value share, driven by advanced healthcare infrastructure, robust R&D investments, and supportive regulatory frameworks. The region leads in adoption due to high demand for precision diagnostics and a mature ecosystem of AI-driven healthcare startups. Europe follows at 25%, fueled by stringent healthcare efficiency mandates, EU-funded AI initiatives, and growing partnerships between tech firms and hospitals. Aging demographics and rising cancer prevalence further accelerate growth.

Asia Pacific is the fastest-growing region, projected to expand at a CAGR of 18% through 2029, with a current 20% value share. Key drivers include surging chronic disease rates, government investments in digital health (e.g., India’s National Digital Health Mission), and a rapidly expanding middle class. Latin America (10%) and Middle East & Africa (10%) exhibit nascent but promising growth, supported by urbanization, telemedicine adoption, and public-private collaborations to address healthcare access gaps. However, infrastructure gaps and funding limitations temper expansion in these regions.

The global artificial intelligence in the medical imaging market growth is poised to reflect regional disparities in maturity and investment. North America and Europe remain pivotal for innovation, while Asia Pacific’s demographic and economic scale positions it as a future growth engine. Regional forecast models highlight the need for tailored strategies to address regulatory, infrastructural, and cultural nuances across markets.

Competitive Landscape

The artificial intelligence in the medical imaging competitive landscape is moderately consolidated, characterized by a mix of global technology leaders, traditional medical device firms, and emerging AI startups. Key competitive levers include product innovation through AI algorithm development, regulatory approvals (e.g., FDA 510(k), CE marking), and strategic partnerships with healthcare providers or data annotation firms. Pricing remains pressure-sensitive due to hospital budget constraints, while differentiation is driven by AI model accuracy, integration with existing imaging workflows, and data privacy compliance. Global players like Siemens and GE Healthcare dominate via established distribution networks, while regional innovators such as Aidoc and Butterfly Network leverage agile R&D to target niche imaging modalities.

Competitive strategies emphasize M&A for IP acquisition, cross-industry partnerships (e.g., NVIDIA’s collaboration with medical imaging OEMs), and localized product adaptations to meet regional healthcare standards. Differentiation factors include proprietary deep learning architectures, cloud-based diagnostic platforms, and hybrid AI-human decision-support models. A significant challenge is rising compliance costs tied to evolving data governance laws (e.g., GDPR, HIPAA), which disproportionately impact smaller firms lacking dedicated regulatory teams. Additionally, commoditization risks emerge as open-source AI frameworks lower entry barriers for new entrants.

NVIDIA Corporation: OEM tie-ups with medical imaging hardware providers for AI integration

GE Healthcare: Regional expansion via partnerships in emerging markets

Siemens: Innovation pipeline focused on multi-modal AI diagnostic tools

Aidoc: R&D investments in radiology-specific anomaly detection algorithms

Agfa Healthcare: Localization of AI solutions for EU healthcare IT infrastructure

IBM Corporation: AI integration with Watson Health for clinical decision support

Key artificial intelligence in the medical imaging Companies11 items

NVIDIA Corporation

GE Healthcare

Siemens

Aidoc

3Scan

Agfa Healthcare

Arterys

Butterfly Network, Inc.

EchoNous, Inc.

Enlitic, Inc.

IBM Corporation

Market Ecosystem

The artificial intelligence in the medical imaging ecosystem spans upstream technology development, midstream solution integration, and downstream clinical deployment. Value is generated through collaborative innovation between technology developers, healthcare infrastructure providers, and regulatory bodies, with end-user adoption determining market scalability. The ecosystem’s complexity arises from interdependencies between data accessibility, algorithmic accuracy, and medical workflow integration across diagnostic, therapeutic, and administrative use cases.

Technology providers — develop AI algorithms, cloud infrastructure, and computational tools for image analysis

Data/analytics providers — supply annotated medical imaging datasets and performance benchmarking tools

System integrators — deploy AI solutions into existing radiology workflows and imaging equipment

Medical imaging OEMs — embed AI capabilities into MRI, CT, and X-ray hardware platforms

Healthcare providers — validate AI outputs in clinical settings and manage patient data governance

Regulators/standards bodies — establish approval frameworks and diagnostic accuracy benchmarks

Service providers — maintain AI system performance and train clinical staff on interpretation protocols

Value capture is concentrated at control points including regulatory approvals, data source exclusivity, and system integration expertise. Dependency risks emerge from limited access to high-quality training datasets and fragmented interoperability standards. Switching costs for end users are driven by the depth of AI integration with legacy imaging systems, while cross-sector partnerships accelerate adoption. Regional variations in healthcare IT infrastructure and diagnostic prioritization further shape ecosystem dynamics.

Recent Industry Insights

The artificial intelligence in the medical imaging industry trends over the past 18 months highlight accelerated innovation, regulatory progress, and strategic alliances. Key developments include partnerships between AI startups and healthcare giants, such as Siemens Healthineers and NVIDIA collaborating to enhance AI-driven diagnostic tools. Mergers & acquisitions have surged, with GE HealthCare acquiring PathAI to integrate advanced machine learning into pathology workflows. Meanwhile, product/technology launches like Philips’ FDA-cleared AI-powered ultrasound suite and Google Health’s expanded cancer detection algorithms underscore the sector’s growth. Regulatory changes have also gained momentum, with the FDA streamlining approvals for AI-based medical devices under its Digital Health Pre-Cert Program, fostering faster market entry. Enterprises are prioritizing shifts in consumer or enterprise trends, focusing on AI solutions for early disease detection and workflow automation, especially in radiology and pathology. Funding rounds reached record levels, with startups like Arterys securing $50 million to scale cloud-based imaging platforms, signaling strong investor confidence in AI’s transformative potential for healthcare.

Analyst Overview

The artificial intelligence in the medical imaging market outlook remains highly attractive, driven by rising demand for precision diagnostics, AI-enabled workflow efficiency, and aging populations fueling healthcare needs. Market attractiveness is amplified by robust adoption in oncology, cardiology, and neurology, where AI enhances early disease detection and reduces diagnostic errors.

Competitive intensity is moderate, with a mix of established medtech firms, AI startups, and big tech players vying for market share. Strategic partnerships and regulatory approvals are critical differentiators, though fragmented innovation and high R&D costs create entry barriers. Collaboration between healthcare providers and AI developers is intensifying to address clinical validation challenges.

Long-term growth is projected to outpace traditional healthcare tech sectors, supported by AI’s role in personalized treatment and predictive analytics. However, scalability depends on overcoming interoperability issues and securing reimbursement models that align with AI-driven outcomes.

Innovation & Risk Insights3 items

Innovation is concentrated in deep learning algorithms, 3D imaging, and real-time diagnostic tools, with startups leading edge advancements.

Demand-supply balance tilts toward deficit, as healthcare demand for AI solutions outpaces the availability of trained professionals and validated models.

Key risks include regulatory scrutiny, data privacy vulnerabilities, and algorithmic bias, which could delay market penetration if unaddressed.

11 items

1. Executive Summary

2. artificial intelligence in the medical imaging Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global artificial intelligence in the medical imaging Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global artificial intelligence in the medical imaging Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Diagnostic Centers

6.2. Global artificial intelligence in the medical imaging Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Digital Pathology

6.2.2. Oncology

6.2.3. Others

6.3. Global artificial intelligence in the medical imaging Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global artificial intelligence in the medical imaging Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global artificial intelligence in the medical imaging Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global artificial intelligence in the medical imaging Market Competition by Key Manufacturers

8.1. Global artificial intelligence in the medical imaging Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global artificial intelligence in the medical imaging: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. NVIDIA Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GE Healthcare

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Siemens

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Aidoc

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. 3Scan

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Agfa Healthcare

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Arterys

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Butterfly Network, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. EchoNous, Inc.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Enlitic, Inc.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. IBM Corporation

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global artificial intelligence in the medical imaging Market

Figure 4: Global artificial intelligence in the medical imaging Market: Drivers

Figure 5: Global artificial intelligence in the medical imaging Market: Challenges

Figure 6: Global artificial intelligence in the medical imaging Market: Trends

Figure 7: Global artificial intelligence in the medical imaging Market: Opportunity

Figure 8: Global artificial intelligence in the medical imaging Market: Restraint

Figure 9: Global artificial intelligence in the medical imaging Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global artificial intelligence in the medical imaging Market Value (USD Million) By Region

Figure 15: Global artificial intelligence in the medical imaging Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global artificial intelligence in the medical imaging Market Value (USD Million) By Region

Figure 23: Global artificial intelligence in the medical imaging Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global artificial intelligence in the medical imaging Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global artificial intelligence in the medical imaging Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global artificial intelligence in the medical imaging Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global artificial intelligence in the medical imaging Market Value (USD Million) By Region

Table 10: Global artificial intelligence in the medical imaging Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global artificial intelligence in the medical imaging Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global artificial intelligence in the medical imaging Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global artificial intelligence in the medical imaging Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: NVIDIA Corporation Basic Information And Sales Area

Table 31: NVIDIA Corporation. Products Portfolio

Table 32: GE Healthcare Basic Information And Sales Area

Table 33: GE Healthcare. Products Portfolio

Table 34: Siemens Basic Information And Sales Area

Table 35: Siemens. Products Portfolio

Table 36: Aidoc Basic Information And Sales Area

Table 37: Aidoc. Products Portfolio

Table 38: 3Scan Basic Information And Sales Area

Table 39: 3Scan. Products Portfolio

Table 40: Agfa Healthcare Basic Information And Sales Area

Table 41: Agfa Healthcare. Products Portfolio

Table 42: Arterys Basic Information And Sales Area

Table 43: Arterys. Products Portfolio

Table 44: Butterfly Network, Inc. Basic Information And Sales Area

Table 45: Butterfly Network, Inc.. Products Portfolio

Table 46: EchoNous, Inc. Basic Information And Sales Area

Table 47: EchoNous, Inc.. Products Portfolio

Table 48: Enlitic, Inc. Basic Information And Sales Area

Table 49: Enlitic, Inc.. Products Portfolio

Table 50: IBM Corporation Basic Information And Sales Area

Table 51: IBM Corporation. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global artificial intelligence in the medical imaging Market Value (USD Million) By Region

Table 57: Global artificial intelligence in the medical imaging Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

artificial intelligence in the medical imaging Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	7.34 billion
Growth rate	CAGR of 25.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	NVIDIA Corporation; GE Healthcare; Siemens; Aidoc; 3Scan; Agfa Healthcare; Arterys; Butterfly Network, Inc.; EchoNous, Inc.; Enlitic, Inc.; IBM Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options